tiprankstipranks
Advertisement
Advertisement

Sleep Cycle teams with Carnegie Mellon to turn cough data into outbreak early-warning signals

Story Highlights
  • Sleep Cycle and CMU’s Delphi Group begin a five-year study using anonymized cough and breathing data to improve U.S. respiratory disease surveillance.
  • The collaboration could validate sleep-app data as an early outbreak indicator, boosting Sleep Cycle’s role in predictive health and public research.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Sleep Cycle teams with Carnegie Mellon to turn cough data into outbreak early-warning signals

Meet Samuel – Your Personal Investing Prophet

The latest update is out from Sleep Cycle AB ( (SE:SLEEP) ).

Sleep Cycle AB, a Gothenburg-headquartered AI sleep technology firm best known for its consumer sleep-tracking app and data-driven wellness tools, continues to expand beyond its core digital sleep services and corporate partnership program. By commercializing its vast global sleep dataset, the company is positioning itself as both a consumer brand and a data partner in the broader digital health and wellness ecosystem.

The company has launched a five-year research collaboration with Carnegie Mellon University’s Delphi Group to test whether anonymized cough and breathing signals from its Cough Radar tool can enhance U.S. respiratory disease surveillance. Under the agreement, Sleep Cycle will provide deidentified, differentially private data for epidemiological modeling, marking the first systematic use of sleep app data by Delphi and potentially elevating Sleep Cycle’s role in public health research and outbreak forecasting.

Researchers will analyze nighttime cough intensity trends as an early indicator of viruses such as influenza, RSV and SARS-CoV-2, with findings to be released over the course of the program. If successful, the work could strengthen national monitoring systems, accelerate detection of seasonal and emerging outbreaks and underscore the value of large-scale, privacy-preserved digital health data, reinforcing Sleep Cycle’s shift from a purely reactive sleep app to a contributor to predictive health and public health decision-making.

The most recent analyst rating on (SE:SLEEP) stock is a Hold with a SEK18.00 price target. To see the full list of analyst forecasts on Sleep Cycle AB stock, see the SE:SLEEP Stock Forecast page.

More about Sleep Cycle AB

Sleep Cycle AB is a Sweden-based AI sleep technology company whose consumer app helps users build healthy sleep habits, identify potential sleep issues and analyze sleep patterns. Leveraging patented sound technology and a data library of more than 3 billion analyzed sleep sessions across 180 countries, the Nasdaq Stockholm-listed group also offers partnerships, SDK solutions and in-app promotions that let businesses integrate sleep insights into their offerings.

Average Trading Volume: 50,487

Technical Sentiment Signal: Sell

Current Market Cap: SEK325.7M

For an in-depth examination of SLEEP stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1